Autism Spectrum Disorder in Fragile X Syndrome: Cooccurring Conditions and Current Treatment

American Academy of Pediatrics (AAP) - Tập 139 Số Supplement_3 - Trang S194-S206 - 2017
Walter E. Kaufmann1,2, Sharon A. Kidd3, Howard Andrews4, Dejan B. Budimirovic5, Amy Esler6, Barbara Haas‐Givler7, Tracy Stackhouse8, Catharine Riley9, Georgina Peacock9, Stephanie L. Sherman10, W. Ted Brown11, Elizabeth Berry‐Kravis12
1Department of Neurology, Boston Children's Hospital, Boston, Massachusetts
2Greenwood Genetic Center, Greenwood, South Carolina
3National Fragile X Foundation, Washington, District of Columbia;
4Department of Biostatistics, Columbia University Mailman School of Public Health, New York, New York
5Kennedy Krieger Institute, Baltimore, Maryland
6University of Minnesota, Minneapolis, Minnesota
7Geisinger Health System, Lewisburg, Pennsylvania;
8Developmental FX, Denver, Colorado;
9National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia
10Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia
11New York State Institute for Basic Research in Developmental Disabilities, Staten Island, New York; and
12Departments of Pediatrics, Neurological Sciences, and Biochemistry, Rush University Medical Center, Chicago, Illinois;

Tóm tắt

BACKGROUND AND OBJECTIVE:

Individuals with fragile X syndrome (FXS) are frequently codiagnosed with autism spectrum disorder (ASD). Most of our current knowledge about ASD in FXS comes from family surveys and small studies. The objective of this study was to examine the impact of the ASD diagnosis in a large clinic-based FXS population to better inform the care of people with FXS.

METHODS:

The study employed a data set populated by data from individuals with FXS seen at specialty clinics across the country. The data were collected by clinicians at the patient visit and by parent report for nonclinical and behavioral outcomes from September 7, 2012 through August 31, 2014. Data analyses were performed by using χ2 tests for association, t tests, and multiple logistic regression to examine the association between clinical and other factors with ASD status.

RESULTS:

Half of the males and nearly 20% of females met Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition criteria for current ASD. Relative to the FXS-only group, the FXS with ASD (FXS+ASD) group had a higher prevalence of seizures (20.7% vs 7.6%, P < .001), persistence of sleep problems later in childhood, increased behavior problems, especially aggressive/disruptive behavior, and higher use of α-agonists and antipsychotics. Behavioral services, including applied behavior analysis, appeared to be underused in children with FXS+ASD (only 26% and 16% in prekindergarten and school-age periods, respectively) relative to other populations with idiopathic ASD.

CONCLUSIONS:

These findings confirm among individuals with FXS an association of an ASD diagnosis with important cooccurring conditions and identify gaps between expected and observed treatments among individuals with FXS+ASD.

Từ khóa


Tài liệu tham khảo

Verkerk, 1991, Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome., Cell, 65, 905, 10.1016/0092-8674(91)90397-H

Yu, 1991, Fragile X genotype characterized by an unstable region of DNA., Science, 252, 1179, 10.1126/science.252.5009.1179

Crawford, 2001, FMR1 and the fragile X syndrome: human genome epidemiology review., Genet Med, 3, 359, 10.1097/00125817-200109000-00006

Coffee, 2009, Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA., Am J Hum Genet, 85, 503, 10.1016/j.ajhg.2009.09.007

Tassone, 2012, FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States., Genome Med, 4, 100, 10.1186/gm401

Boyle, 2010, The behavioral phenotype of FMR1 mutations., Am J Med Genet C Semin Med Genet, 154C, 469, 10.1002/ajmg.c.30277

Hagerman, 2009, Advances in the treatment of fragile X syndrome., Pediatrics, 123, 378, 10.1542/peds.2008-0317

Abrams, 1994, Molecular-neurobehavioral associations in females with the fragile X full mutation., Am J Med Genet, 51, 317, 10.1002/ajmg.1320510407

Loesch, 2004, Phenotypic variation and FMRP levels in fragile X., Ment Retard Dev Disabil Res Rev, 10, 31, 10.1002/mrdd.20006

Muhle, 2004, The genetics of autism., Pediatrics, 113, 10.1542/peds.113.5.e472

Schaefer, 2013, Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions., Genet Med, 15, 399, 10.1038/gim.2013.32

American Psychiatric Association, 2013, Diagnostic and Statistical Manual of Mental Disorders, 5th ed., 10.1176/appi.books.9780890425596

Talisa, 2014, Autism and anxiety in males with fragile X syndrome: an exploratory analysis of neurobehavioral profiles from a parent survey., Am J Med Genet A, 164A, 1198, 10.1002/ajmg.a.36468

Budimirovic, 2011, What can we learn about autism from studying fragile X syndrome?, Dev Neurosci, 33, 379, 10.1159/000330213

Hagerman, 2002, Fragile X Syndrome: Diagnosis, Treatment, and Research, 3rd ed., 10.56021/9780801868436

Clifford, 2007, Autism spectrum phenotype in males and females with fragile X full mutation and premutation., J Autism Dev Disord, 37, 738, 10.1007/s10803-006-0205-z

Hall, 2008, Compulsive, self-injurious, and autistic behavior in children and adolescents with fragile X syndrome., Am J Ment Retard, 113, 44, 10.1352/0895-8017(2008)113[44:CSAABI]2.0.CO;2

Harris, 2008, Autism profiles of males with fragile X syndrome., Am J Ment Retard, 113, 427, 10.1352/2008.113:427-438

Bailey, 2008, Co-occurring conditions associated with FMR1 gene variations: findings from a national parent survey., Am J Med Genet A, 146A, 2060, 10.1002/ajmg.a.32439

Kaufmann, 2004, Autism spectrum disorder in fragile X syndrome: communication, social interaction, and specific behaviors., Am J Med Genet A, 129A, 225, 10.1002/ajmg.a.30229

Budimirovic, 2006, Autism spectrum disorder in fragile X syndrome: differential contribution of adaptive socialization and social withdrawal., Am J Med Genet A, 140A, 1814, 10.1002/ajmg.a.31405

Hernandez, 2009, Autism spectrum disorder in fragile X syndrome: a longitudinal evaluation., Am J Med Genet A, 149A, 1125, 10.1002/ajmg.a.32848

Lewis, 2006, Cognitive, language and social-cognitive skills of individuals with fragile X syndrome with and without autism., J Intellect Disabil Res, 50, 532, 10.1111/j.1365-2788.2006.00803.x

Hall, 2008, Longitudinal changes in intellectual development in children with Fragile X syndrome., J Abnorm Child Psychol, 36, 927, 10.1007/s10802-008-9223-y

Hall, 2010, Autism in fragile X syndrome: a category mistake?, J Am Acad Child Adolesc Psychiatry, 49, 921, 10.1016/j.jaac.2010.07.001

Philofsky, 2004, Linguistic and cognitive functioning and autism symptoms in young children with fragile X syndrome., Am J Ment Retard, 109, 208, 10.1352/0895-8017(2004)109<208:LACFAA>2.0.CO;2

Hatton, 2006, Autistic behavior in children with fragile X syndrome: prevalence, stability, and the impact of FMRP., Am J Med Genet A, 140A, 1804, 10.1002/ajmg.a.31286

Kaufmann, 2008, Current Theories and Evidence, 81, 10.1007/978-1-60327-489-0_4

McDuffie, 2010, Autism spectrum disorder in children and adolescents with fragile X syndrome: within-syndrome differences and age-related changes., Am J Intellect Dev Disabil, 115, 307, 10.1352/1944-7558-115.4.307

Sullivan, 2006, ADHD symptoms in children with FXS., Am J Med Genet A, 140, 2275, 10.1002/ajmg.a.31388

Cordeiro, 2011, Clinical assessment of DSM-IV anxiety disorders in fragile X syndrome: prevalence and characterization., J Neurodev Disord, 3, 57, 10.1007/s11689-010-9067-y

Berry-Kravis, 2010, Seizures in fragile X syndrome: characteristics and comorbid diagnoses., Am J Intellect Dev Disabil, 115, 461, 10.1352/1944-7558-115.6.461

Bölte, 2008, Assessing autistic traits: cross-cultural validation of the social responsiveness scale (SRS)., Autism Res, 1, 354, 10.1002/aur.49

Frazier, 2014, Confirmatory factor analytic structure and measurement invariance of quantitative autistic traits measured by the social responsiveness scale-2., Autism, 18, 31, 10.1177/1362361313500382

Corsello, 2007, Between a ROC and a hard place: decision making and making decisions about using the SCQ., J Child Psychol Psychiatry, 48, 932, 10.1111/j.1469-7610.2007.01762.x

Norris, 2010, Screening accuracy of level 2 autism spectrum disorder rating scales. a review of selected instruments., Autism, 14, 263, 10.1177/1362361309348071

Aman, 1985, The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects., Am J Ment Defic, 89, 485

Kaat, 2014, Validity of the aberrant behavior checklist in children with autism spectrum disorder., J Autism Dev Disord, 44, 1103, 10.1007/s10803-013-1970-0

Kidd, 2014, Fragile X syndrome: a review of associated medical problems., Pediatrics, 134, 995, 10.1542/peds.2013-4301

Heard, 2014, EEG abnormalities and seizures in genetically diagnosed Fragile X syndrome., Int J Dev Neurosci, 38, 155, 10.1016/j.ijdevneu.2014.07.002

Lee, 2015, Autism spectrum disorder and epilepsy: disorders with a shared biology., Epilepsy Behav, 47, 191, 10.1016/j.yebeh.2015.03.017

Kronk, 2010, Prevalence, nature, and correlates of sleep problems among children with fragile X syndrome based on a large scale parent survey., Sleep, 33, 679, 10.1093/sleep/33.5.679

Kronk, 2009, Caregiver reports of sleep problems on a convenience sample of children with fragile X syndrome., Am J Intellect Dev Disabil, 114, 383, 10.1352/1944-7588-114.6.383

Souders, 2009, Sleep behaviors and sleep quality in children with autism spectrum disorders., Sleep, 32, 1566, 10.1093/sleep/32.12.1566

Goodlin-Jones, 2009, Six-month persistence of sleep problems in young children with autism, developmental delay, and typical development., J Am Acad Child Adolesc Psychiatry, 48, 847, 10.1097/CHI.0b013e3181a8135a

Krakowiak, 2008, Sleep problems in children with autism spectrum disorders, developmental delays, and typical development: a population-based study., J Sleep Res, 17, 197, 10.1111/j.1365-2869.2008.00650.x

Rosenberg, 2011, Parent report of community psychiatric comorbid diagnoses in autism spectrum disorders., Autism Res Treat, 2011, 405849

Berry-Kravis, 2004, Psychopharmacology in fragile X syndrome–present and future., Ment Retard Dev Disabil Res Rev, 10, 42, 10.1002/mrdd.20007

Erickson, 2011, A prospective open-label study of aripiprazole in fragile X syndrome., Psychopharmacology (Berl), 216, 85, 10.1007/s00213-011-2194-7

Hagerman, 2015, Treatment of the psychiatric problems associated with fragile X syndrome., Curr Opin Psychiatry, 28, 107, 10.1097/YCO.0000000000000131

Bailey, 2012, Medication utilization for targeted symptoms in children and adults with fragile X syndrome: US survey., J Dev Behav Pediatr, 33, 62, 10.1097/DBP.0b013e318236c0e1

Valdovinos, 2009, Results of a nation-wide survey evaluating psychotropic medication use in fragile X syndrome., J Dev Phys Disabil, 21, 23, 10.1007/s10882-008-9123-7

Erickson, 2010, Aripiprazole in autism spectrum disorders and fragile X syndrome., Neurotherapeutics, 7, 258, 10.1016/j.nurt.2010.04.001

Odom, 2010, Evaluation of comprehensive treatment models for individuals with autism spectrum disorders., J Autism Dev Disord, 40, 425, 10.1007/s10803-009-0825-1

Buescher, 2014, Costs of autism spectrum disorders in the United Kingdom and the United States., JAMA Pediatr, 168, 721, 10.1001/jamapediatrics.2014.210

Reichow, 2013, Non-specialist psychosocial interventions for children and adolescents with intellectual disability or lower-functioning autism spectrum disorders: a systematic review., PLoS Med, 10, e1001572, 10.1371/journal.pmed.1001572

Martin, 2013, Therapy service use among individuals with fragile X syndrome: findings from a US parent survey., J Intellect Disabil Res, 57, 837, 10.1111/j.1365-2788.2012.01608.x

Chiri, 2012, Unmet need and problems accessing core health care services for children with autism spectrum disorder., Matern Child Health J, 16, 1081, 10.1007/s10995-011-0833-6

Green, 2006, Internet survey of treatments used by parents of children with autism., Res Dev Disabil, 27, 70, 10.1016/j.ridd.2004.12.002

Elsabbagh, 2012, Global prevalence of autism and other pervasive developmental disorders., Autism Res, 5, 160, 10.1002/aur.239

Farmer, 2013, Pharmacotherapy for the core symptoms in autistic disorder: current status of the research., Drugs, 73, 303, 10.1007/s40265-013-0021-7

Matson, 2007, Comorbid psychopathology with autism spectrum disorder in children: an overview., Res Dev Disabil, 28, 341, 10.1016/j.ridd.2005.12.004

Iadarola, 2015, Services for children with autism spectrum disorder in three, large urban school districts: perspectives of parents and educators., Autism, 19, 694, 10.1177/1362361314548078

Whalon, 2015, School-based peer-related social competence interventions for children with autism spectrum disorder: a meta-analysis and descriptive review of single case research design studies., J Autism Dev Disord, 45, 1513, 10.1007/s10803-015-2373-1

Moss, 2009, Autism spectrum disorders in genetic syndromes: implications for diagnosis, intervention and understanding the wider autism spectrum disorder population., J Intellect Disabil Res, 53, 852, 10.1111/j.1365-2788.2009.01197.x

Kau, 2004, Social behavior profile in young males with fragile X syndrome: characteristics and specificity., Am J Med Genet A, 126A, 9, 10.1002/ajmg.a.20218

Wolff, 2012, Evidence of a distinct behavioral phenotype in young boys with fragile X syndrome and autism., J Am Acad Child Adolesc Psychiatry, 51, 1324, 10.1016/j.jaac.2012.09.001

Wheeler, 2015, DSM-5 changes and the prevalence of parent-reported autism spectrum symptoms in fragile X syndrome., J Autism Dev Disord, 45, 816, 10.1007/s10803-014-2246-z

Warren, 2011, Therapies for Children With Autism Spectrum Disorders